S2369 A Unique Case of Pancreatic Leukocyte Chemotactic Factor 2 Amyloidosis (ALECT2)

Steven D. Ma,Andrew Bell,Kevin Liu
DOI: https://doi.org/10.14309/01.ajg.0001038844.48707.c9
2024-10-26
The American Journal of Gastroenterology
Abstract:Amyloidosis derived from leukocyte chemotactic factor 2 (ALECT2) is a rare, systemic amyloidosis that typically affects the kidney and liver. It has strong associations with Hispanic ethnicities and is a newly described disease process first documented in 2008. ALECT2 is typically an indolent disorder. If affected, most patients present with chronic renal insufficiency. However, there is growing evidence of ALECT2 involvement with liver pathology. No prior case report has described pancreatic involvement of ALECT2. Here we present a case of a patient who was found to have ALECT2 after endoscopic ultrasound (EUS)-guided fine needle biopsy (FNB) of a pancreatic tail mass.
gastroenterology & hepatology
What problem does this paper attempt to address?